SCHEMBL4564707

SCHEMBL4564707

COc1ccc2[nH]c(S(=O)(=O)NCc3ncc(C)c(OC)c3C)nc2c1.[MgH2]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.61
KMT2A Q03164 5/20 0.49
WDR5 P61964 3/20 0.49
BRS3 P32247 2/20 0.49
ATP1A1 P05023 2/20 0.49
ATP1B1 P05026 2/20 0.49
ATP1A3 P13637 2/20 0.49
ATP1B2 P14415 2/20 0.49
ATP4A P20648 2/20 0.49
ATP1A2 P50993 2/20 0.49
ATP4B P51164 2/20 0.49
ATP1B3 P54709 2/20 0.49
FXYD2 P54710 2/20 0.49
ATP1A4 Q13733 2/20 0.49
DDAH1 O94760 2/20 0.49
ENGASE Q8NFI3 2/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP1A2 P05177 2/20 0.49
MAPT P10636 2/20 0.49
CYP2C19 P33261 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL4565659 0.99 CYP2C9 (0.60) CYP2C9KMT2AWDR5BRS3ATP1A1
SCHEMBL1907465 0.99 CYP2C9 (0.62) CYP2C9KMT2AWDR5BRS3ATP1A1
SCHEMBL8787822 0.98 CYP2C9 (0.61) CYP2C9KMT2AWDR5BRS3ATP1A1
SCHEMBL8787829 0.98 CYP2C9 (0.61) CYP2C9KMT2AWDR5BRS3ATP1A1
Water SCHEMBL7174113 0.98 CYP2C9 (0.61) CYP2C9KMT2AWDR5BRS3ATP1A1
SCHEMBL4564490 0.98 CYP2C9 (0.61) CYP2C9KMT2AWDR5BRS3ATP1A1
SCHEMBL15232323 0.91 CYP2C9 (0.74) CYP2C9KMT2AWDR5BRS3ATP1A1
SCHEMBL3807887 0.89 CYP2C9 (0.49) CYP2C9KMT2AWDR5BRS3ATP1A1
Omeprazole Sulfone SCHEMBL29415504 0.84 CYP2C9 (0.85) CYP2C9KMT2AWDR5BRS3ATP1A1
Omeprazole Sulfone SCHEMBL33721996 0.84 CYP2C9 (0.85) CYP2C9KMT2AWDR5BRS3ATP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009074997-A2 A NOVEL PROCESS FOR THE PREPARATION OF CRYSTALLINE MAGNESIUM SALT OF (S)-OMEPRAZOLE DI HYDRATE LEE PHARMA LTD. (IN) 2009-06-18 WO disclosed
US-20030004190-A1 Process ASTRAZENECA AB (SE) 2003-01-02 US disclosed